Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1980 Apr;28(1):171–177. doi: 10.1128/iai.28.1.171-177.1980

Comparative Antigenicity and Immunogenicity of A/USSR/77 Influenza Vaccines in Normal and Primed Mice

Colin McLaren 1,†, George E Grubbs 1, Eldridge Staton 1, William Barthlow 1, Gerald Quinnan 1, Francis A Ennis 1
PMCID: PMC550908  PMID: 7380562

Abstract

In response to the threat of wide-spread epidemics of influenza in the United States due to the A/USSR/77 strain of virus, vaccines containing A/USSR/77 virus were prepared by four manufacturers. The vaccines were standardized by immunological measurements of viral hemagglutinin and were tested for their ability to induce serum hemagglutination-inhibiting antibodies in mice and to protect the animals against challenge infection with A/USSR/77 virus. Whole-virus and subunit virus vaccines were found to be equally efficacious, in contrast to our previous findings with vaccines prepared from other influenza virus strains. The effect of priming animals by infection with representative viruses of earlier eras on their response to A/USSR/77 vaccines was also studied. Enhanced responses were noted to both subunit and whole-virus A/USSR/77 vaccines in animals primed with viruses prevalent before 1957; higher antibody titers were induced with the subunit vaccine. A high degree of heterologous protection to A/USSR/77 challenge infection was found in mice primed with virus strains having hemagglutinin antigens unlike those of A/USSR/77 virus. Comparison of the responses of mice with those of humans inoculated with the same vaccines showed a similarity in many instances, with higher responses in those individuals primed with H0N1 and H1N1 viruses than in younger vaccinees.

Full text

PDF
171

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barry D. W., Staton E., Mayner R. E. Inactivated influenza vaccine efficacy: diminished antigenicity of split-product vaccines in mice. Infect Immun. 1974 Dec;10(6):1329–1336. doi: 10.1128/iai.10.6.1329-1336.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Effros R. B., Doherty P. C., Gerhard W., Bennink J. Generation of both cross-reactive and virus-specific T-cell populations after immunization with serologically distinct influenza A viruses. J Exp Med. 1977 Mar 1;145(3):557–568. doi: 10.1084/jem.145.3.557. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Ennis F. A., Martin W. J., Verbonitz M. W., Butchko G. M. Specificity studies on cytotoxic thymus-derived lymphocytes reactive with influenza virus-infected cells: evidence for dual recognition of H-2 and viral hemagglutinin antigens. Proc Natl Acad Sci U S A. 1977 Jul;74(7):3006–3010. doi: 10.1073/pnas.74.7.3006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Ennis F. A., Mayner R. E., Barry D. W., Manischewitz J. E., Dunlap R. C., Verbonitz M. W., Bozeman R. M., Schild G. C. Correlation of laboratory studies with clinical responses to A/New Jersey influenza vaccines. J Infect Dis. 1977 Dec;136 (Suppl):S397–S406. doi: 10.1093/infdis/136.supplement_3.s397. [DOI] [PubMed] [Google Scholar]
  5. Ennis F. A., Wells M. A., Barry D. W., Daniel S., Manischewitz J. Host defence mechanisms against influenza infection. II. Protection of mice with vaccines against A/Port Chalmers/1/73 and B/Hong Kong/5/72. Postgrad Med J. 1976 Jun;52(608):338–344. doi: 10.1136/pgmj.52.608.338. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Floc'h F., Werner G. H. Heterotypic protective immune reactions in mice infected with distinct serotypes of human influenza virus. Ann Microbiol (Paris) 1978 May-Jun;129(4):509–524. [PubMed] [Google Scholar]
  7. Kendal A. P., Noble G. R., Skehel J. J., Dowdle W. R. Antigenic similarity of influenza A (H1N1) viruses from epidemics in 1977--1978 to "Scandinavian" strains isolated in epidemics of 1950--1951. Virology. 1978 Sep;89(2):632–636. doi: 10.1016/0042-6822(78)90207-6. [DOI] [PubMed] [Google Scholar]
  8. Mayner R. E., Blackburn R. J., Barry D. W. Quantitation of influenza vaccine hemagglutinin by immunoelectrophoresis. Dev Biol Stand. 1977 Jun 1;39:169–178. [PubMed] [Google Scholar]
  9. McLaren C., Potter C. W., Jennings R. Immunity to influenza in ferrets. 13. Protection against influenza infection by serum antibody to homologous haemagglutinin or neuraminidase antigens. Med Microbiol Immunol. 1974;160(1):33–45. doi: 10.1007/BF02124341. [DOI] [PubMed] [Google Scholar]
  10. McLaren C., Potter C. W., Jennings R. Immunity to influenza in ferrets. XI. Cross-immunity between A/Hong Kong/68 and A/England/72 viruses: serum antibodies produced by infection or immunization. J Hyg (Lond) 1974 Dec;73(3):389–399. doi: 10.1017/s0022172400042741. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. McLaren C., Verbonitz M. W., Daniel S., Grubbs G. E., Ennis F. A. Effect of priming infection on serologic response to whole and subunit influenza virus vaccines in animals. J Infect Dis. 1977 Dec;136 (Suppl):S706–S711. doi: 10.1093/infdis/136.supplement_3.s706. [DOI] [PubMed] [Google Scholar]
  12. McLaren C., Williams M. S., Bozeman F. M., Mayner R. E., Grubbs G. E., Barthlow W. E., Staton E., Ennis F. A. Comparative antigenicity and immunogenicity of 1976 influenza virus vaccines: results of mouse protection experiments. J Biol Stand. 1978 Oct;6(4):315–330. doi: 10.1016/s0092-1157(78)80020-1. [DOI] [PubMed] [Google Scholar]
  13. SCHULMAN J. L., KILBOURNE E. D. INDUCTION OF PARTIAL SPECIFIC HETEROTYPIC IMMUNITY IN MICE BY A SINGLE INFECTION WITH INFLUENZA A VIRUS. J Bacteriol. 1965 Jan;89:170–174. doi: 10.1128/jb.89.1.170-174.1965. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Schulman J. L. Experimental transmission of influenza virus infection in mice. 3. Differing effects of immunity induced by infection and by inactivated influenza virus vaccine on transmission of infection. J Exp Med. 1967 Mar 1;125(3):467–478. doi: 10.1084/jem.125.3.467. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Tauraso N. M., O'Brien T. C., Seligman E. B., Jr Problems of influenza virus vaccine standardization. Bull World Health Organ. 1969;41(3):497–506. [PMC free article] [PubMed] [Google Scholar]
  16. Werner G. H. Immunité croisée hétérotypique chez la souris entre virus grippaux humains de types A et A2. C R Acad Sci Hebd Seances Acad Sci D. 1966 Dec 7;263(23):1913–1916. [PubMed] [Google Scholar]
  17. Wood J. M., Schild G. C., Newman R. W., Seagroatt V. Application of an improved single-radial-immunodiffusion technique for the assay of haemagglutinin antigen content of whole virus and subunit influenza vaccines. Dev Biol Stand. 1977 Jun 1;39:193–200. [PubMed] [Google Scholar]
  18. Zweerink H. J., Courtneidge S. A., Skehel J. J., Crumpton M. J., Askonas B. A. Cytotoxic T cells kill influenza virus infected cells but do not distinguish between serologically distinct type A viruses. Nature. 1977 May 26;267(5609):354–356. doi: 10.1038/267354a0. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES